CSBR:NASDAQ
Champions Oncology Inc
4,34 US$
arrow_downward
-1,36%(-0,060) 1D
20 ნოე, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,45 US$
High
4,45 US$
Low
4,34 US$
Mkt. cap
60,41 მლნ.
Avg. vol.
6,97 ათ.
Volume
8,94 ათ.
52-wk high
8,31 US$
52-wk low
4,34 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
Open
4,45 US$
High
4,45 US$
Low
4,34 US$
Mkt. cap
60,41 მლნ.
Avg. vol.
6,97 ათ.
Volume
8,94 ათ.
52-wk high
8,31 US$
52-wk low
4,34 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
News stories
From web sources and news partners
FOREX.com
·
2 საათის წინ
S&P 500, Nasdaq 100 Drive into Correction Territory
TradingView
·
4 საათის წინ
Ed Yardeni Says Investors Are Overreacting to S&P 500 Selloff
TradingKey
·
7 საათის წინ
S&P 500 Falls Below 200-Day Moving Average: Buy-the-Dip Opportunity or Bear Market Warning?
cwibc.co.id
·
2 საათის წინ
Wall Street Sell-Off Pushes S&P 500 and Dow Into Correction
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ნიუ-ჯერსი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitechampionsoncology.com